These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 17311010

  • 21. In vivo delivery of human alpha-L-iduronidase in mice implanted with neo-organs.
    Salvetti A, Moullier P, Cornet V, Brooks D, Hopwood JJ, Danos O, Heard JM.
    Hum Gene Ther; 1995 Sep; 6(9):1153-9. PubMed ID: 8527473
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Reversal of lysosomal storage in brain of adult MPS-I mice with intravenous Trojan horse-iduronidase fusion protein.
    Boado RJ, Hui EK, Lu JZ, Zhou QH, Pardridge WM.
    Mol Pharm; 2011 Aug 01; 8(4):1342-50. PubMed ID: 21667973
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs.
    Mango RL, Xu L, Sands MS, Vogler C, Seiler G, Schwarz T, Haskins ME, Ponder KP.
    Mol Genet Metab; 2004 May 01; 82(1):4-19. PubMed ID: 15110316
    [Abstract] [Full Text] [Related]

  • 31. Liver-directed gene therapy corrects cardiovascular lesions in feline mucopolysaccharidosis type I.
    Hinderer C, Bell P, Gurda BL, Wang Q, Louboutin JP, Zhu Y, Bagel J, O'Donnell P, Sikora T, Ruane T, Wang P, Haskins ME, Wilson JM.
    Proc Natl Acad Sci U S A; 2014 Oct 14; 111(41):14894-9. PubMed ID: 25267637
    [Abstract] [Full Text] [Related]

  • 32. Myoblast gene therapy in canine mucopolysaccharidosis. I: Abrogation by an immune response to alpha-L-iduronidase.
    Shull RM, Lu X, McEntee MF, Bright RM, Pepper KA, Kohn DB.
    Hum Gene Ther; 1996 Aug 20; 7(13):1595-603. PubMed ID: 8864760
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Systemic correction of storage disease in MPS I NOD/SCID mice using the sleeping beauty transposon system.
    Aronovich EL, Bell JB, Khan SA, Belur LR, Gunther R, Koniar B, Schachern PA, Parker JB, Carlson CS, Whitley CB, McIvor RS, Gupta P, Hackett PB.
    Mol Ther; 2009 Jul 20; 17(7):1136-44. PubMed ID: 19384290
    [Abstract] [Full Text] [Related]

  • 36. Intra-articular nonviral gene therapy in mucopolysaccharidosis I mice.
    Bidone J, Schuh RS, Farinon M, Poletto É, Pasqualim G, de Oliveira PG, Fraga M, Xavier RM, Baldo G, Teixeira HF, Matte U.
    Int J Pharm; 2018 Sep 05; 548(1):151-158. PubMed ID: 29940298
    [Abstract] [Full Text] [Related]

  • 37. Targeting a Pre-existing Anti-transgene T Cell Response for Effective Gene Therapy of MPS-I in the Mouse Model of the Disease.
    Squeri G, Passerini L, Ferro F, Laudisa C, Tomasoni D, Deodato F, Donati MA, Gasperini S, Aiuti A, Bernardo ME, Gentner B, Naldini L, Annoni A, Biffi A, Gregori S.
    Mol Ther; 2019 Jul 03; 27(7):1215-1227. PubMed ID: 31060789
    [Abstract] [Full Text] [Related]

  • 38. Correction of mucopolysaccharidosis type I fibroblasts by retroviral-mediated transfer of the human alpha-L-iduronidase gene.
    Anson DS, Bielicki J, Hopwood JJ.
    Hum Gene Ther; 1992 Aug 03; 3(4):371-9. PubMed ID: 1525210
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.